Thermo Fisher Scientific to acquire Brammer Bio for $1.7 billion in cash
Thermo Fisher Scientific announced they have entered into a definitive agreement whereby Thermo Fisher will acquire Brammer Bio for $1.7 billion in cash. Brammer Bio is a leading viral vector CDMO. The business has nearly 600 employees at primary locations in Massachusetts and Florida. March 24, 2019